openPR Logo
Press release

Angiotensin Receptor Blockers (ARBs) Market 2024 Trends, Analysis, Key Players, Growth Opportunities 2024-2033

02-27-2024 07:49 AM CET | Health & Medicine

Press release from: The Business research company

Angiotensin Receptor Blockers (ARBs) Market

Angiotensin Receptor Blockers (ARBs) Market

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Angiotensin Receptor Blockers (ARBs) Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The angiotensin receptor blockers (arbs) market size has grown steadily in recent years. It will grow from $8.26 billion in 2023 to $8.62 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to hypertension epidemic, clinical efficacy, cardiovascular disease burden, renal protection, clinical guidelines, arbs as first-line treatment, cost-effectiveness.

The angiotensin receptor blockers (arbs) market size is expected to see steady growth in the next few years. It will grow to $10.28 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to precision medicine approaches, focus on combination therapies, global expansion of market, biomarker-based treatment strategies, government initiatives, increased awareness of hypertension. Major trends in the forecast period include telemedicine adoption, research and development investments, generic competition and patent expirations, digital health solutions for medication adherence, biosimilar competition.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8943&type=smp

Market Segmentation:
The angiotensin receptor blockers (arbs) market covered in this report is segmented -
1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers

Major Driver - Rising Cardiovascular Disease Incidence Sparks Surge In Angiotensin Receptor Blockers Market
The increasing incidence of cardiovascular diseases is expected to propel the growth of the angiotensin receptor blockers market going forward. Cardiovascular disease (CVD) is any condition affecting the heart or blood vessels. It is frequently associated with the development of fatty deposits within the arteries (atherosclerosis) and an increased risk of blood clots. Angiotensin receptor blockers lower blood pressure and improve the heart's capacity to pump blood by helping in vein and artery relaxation, which can minimize the risk of cardiovascular disease. For instance, in August 2022, according to the American College of Cardiology, a US-based professional medical organization, the expected rates of cardiovascular risk factors and disease will considerably rise in the United States by the year 2060. Therefore, the increasing incidence of cardiovascular diseases is driving the growth of the angiotensin receptor blockers market.

Competitive Landscape:
Major companies operating in the angiotensin receptor blockers (arbs) market report are Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Movianto, Clinical Trial Logistics, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma .

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/angiotensin-receptor-blockers-arbs-global-market-report

Top Trend - Innovative Product Solution In The Angiotensin Receptor Blockers Market
Product innovation is a key trend in gaining popularity in the angiotensin receptor blockers market. Major companies operating in the angiotensin receptor blocker market are focused on developing innovative solutions to strengthen their position in the market. For instance, in February 2021, Novartis AG, a Switzerland-based pharmaceutical company, launched Entresto (sacubitril/valsartan). Entresto (sacubitril/valsartan) has been granted an expanded indication by the United States Food and Drug Administration to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. The clinical benefits are most noticeable in patients with a lower-than-normal left ventricular ejection fraction (LVEF). Entresto is the first and only therapy approved in the United States to treat patients with guideline-defined heart failure, which includes both those with heart failure with reduced ejection fraction (HFrEF) and many with heart failure with preserved ejection fraction (HFpEF).

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Angiotensin Receptor Blockers (ARBs) Market Characteristics
3. Angiotensin Receptor Blockers (ARBs) Market Trends And Strategies
4. Angiotensin Receptor Blockers (ARBs) Market - Macro Economic Scenario
5. Angiotensin Receptor Blockers (ARBs) Market Size And Growth
…..
27. Angiotensin Receptor Blockers (ARBs) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Angiotensin Receptor Blockers (ARBs) Market 2024 Trends, Analysis, Key Players, Growth Opportunities 2024-2033 here

News-ID: 3400732 • Views:

More Releases from The Business research company

Streaming Revolution: Video Streaming Software Market Surges, Forecasted to Reach $22.7B by 2028
Streaming Revolution: Video Streaming Software Market Surges, Forecasted to Reac …
The video streaming software market size has grown rapidly in recent years. It will grow from $9.29 billion in 2023 to $10.96 billion in 2024 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to proliferation of high-speed Internet, rise of over-the-top (OTT) platforms, increased smartphone adoption, content digitization, global expansion of streaming services. The video streaming software market size is expected
Vegetable Farming Market Growth: Trends, Insights, and Innovations Driving Strong Expansion to $2169.93B by 2028
Vegetable Farming Market Growth: Trends, Insights, and Innovations Driving Stron …
The vegetable farming market size has grown strongly in recent years. It will grow from $1649.1 billion in 2023 to $1755.75 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to population growth, health and wellness trends, urbanization, changing dietary patterns, government policies. The vegetable farming market size is expected to see strong growth in the next few years.
Mass Transit Security Market Research and Strategies for Expansion 2024-2033: Aligning Trends, Growth
Mass Transit Security Market Research and Strategies for Expansion 2024-2033: Al …
The mass transit security market size has grown strongly in recent years. It will grow from $39.76 billion in 2023 to $42.88 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to public transportation systems, demand for innovative security solutions, increased investments in advanced surveillance, increased access control systems, increased biometrics, security breaches. The mass transit security market
Human Microchipping Market Key Drivers, Market Research, Insights, and Report 2024-2033: A Strategic Examination
Human Microchipping Market Key Drivers, Market Research, Insights, and Report 20 …
The human microchipping market size has grown strongly in recent years. It will grow from $1.71 billion in 2023 to $1.85 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to breakthroughs in semiconductor technology and miniaturization, rising concerns about identity theft, data breaches, and unauthorized access, increasing demand for medical implants and devices, companies started exploring

All 5 Releases


More Releases for Angiotensin

Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report
Angiotensin II Receptor Blocker (ARBs) API Market To Upscale Amidst Technologica …
The professional intelligence report presents a comprehensive evaluation of various factors that may influence the future performance of the Global Angiotensin II Receptor Blocker (ARBs) API Market during the forecast period of 2021 to 2027. It highlights a host of interlinked factors that may create promising growth opportunities in the global Angiotensin II Receptor Blocker (ARBs) API market in coming years. It also provides holistic perspective regarding different trends that
Angiotensin Modulators Market 2020 Clinical Survey Report to 2026
Angiotensin Modulators -Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Angiotensin Modulators Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has
Angiotensin Receptor Antagonists Market: The 2020-2030 Market and Growth Factor …
The study of Angiotensin Receptor Antagonists Market published by Prophecy Market Insights offerings all compilation of the historical, current and future outlook of the market. This report is very helpful for understanding the market complexity. This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue etc.
Type 2 Angiotensin II Receptor Global Market Research Report 2025
Type 2 Angiotensin II Receptor Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/type-2-angiotensin-ii-receptor-market/80995 The report firstly introduced the Type 2 Angiotensin II
Angiotensin Converting Enzyme Inhibitors Market to Develop Rapidly by 2025
Angiotensin converting enzyme inhibitors are a group of drugs used for the treatment of heart failure, high blood pressure (hypertension), or decrease complications of myocardial infarction (heart attack). These drugs are also useful in slowing down kidney disease progression in patients with chronic kidney disease or kidney disease in diabetic patients. The mechanism of action of angiotensin converting enzyme inhibitors is to decrease the amount of angiotensin II produced. Angiotensin